缺氧(环境)
CYP1A2
化学
药代动力学
茶碱
药理学
维拉帕米
药物代谢
非特异性单加氧酶
内科学
细胞色素P450
内分泌学
新陈代谢
医学
氧气
生物化学
有机化学
钙
作者
Michael Streit,Christoph G�ggelmann,Christoph Dehnert,Jürgen Burhenne,Klaus‐Dieter Riedel,Elmar Menold,Gerd Mikus,P. B rtsch,Walter E. Haefeli
标识
DOI:10.1007/s00228-004-0886-1
摘要
To investigate the effect of acute hypoxia and concomitant changes in portal blood flow on the disposition of drugs mainly metabolized by the cytochrome P450 enzymes (CYP) 3A4 (verapamil) and CYP1A2 (theophylline). Twenty healthy male participants were studied on two 14-h study days in a normobaric hypoxic chamber and were allocated randomly to one of two groups receiving short infusions of either theophylline (6 mg kg −1 body weight) or verapamil (5 mg) intravenously. According to a randomized, cross-over design, participants were once exposed to normoxia and once to hypoxia (12% oxygen corresponding to the ambient PO2 at an altitude of 4,500 m above sea level). The concentrations of theophylline, 1,3-dimethyluric acid, verapamil, and norverapamil were determined in serial blood samples by means of liquid chromatography–mass spectrometry (LC/MS/MS). Portal blood flow was assessed by transabdominal duplex ultrasonography. Acute hypoxia did not alter the pharmacokinetics of theophylline [half-life±SD: 9.29±1.77 versus 9.39±1.40 (hypoxia)], 1,3-dimethyluric acid (12.9±4.72 versus 15.1±8.59), verapamil (2.00±0.98 versus 1.79±0.58), or norverapamil (7.98±2.94 versus 9.91±6.40). Individual changes of elimination half-life and changes in capillary oxygen saturation, PO2, or portal vein flow were not correlated. Portal vein flow was unaffected by hypoxia. Acute hypoxia corresponding to hypoxia at altitudes of 4,500 m does not impair the metabolism mediated by CYP1A2 or CYP3A4. At rapid ascent to and short-term stay at altitudes up to 4,500 m, the doses of drugs metabolized by these CYPs do therefore not require dose modification, and major changes in the disposition of already administered drugs are not to be expected.
科研通智能强力驱动
Strongly Powered by AbleSci AI